These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8324908)
1. Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes. Gerdes AM; Hørder M; Bonnevie-Nielsen V Clin Exp Immunol; 1993 Jul; 93(1):93-6. PubMed ID: 8324908 [TBL] [Abstract][Full Text] [Related]
2. Localization of 2',5'-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-alpha A/D in the mouse brain. Asada-Kubota M; Ueda T; Nakashima T; Kobayashi M; Shimada M; Takeda K; Hamada K; Maekawa S; Sokawa Y Anat Embryol (Berl); 1997 Mar; 195(3):251-7. PubMed ID: 9084823 [TBL] [Abstract][Full Text] [Related]
3. Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2', 5'-oligoadenylate synthetase in cells persistently infected with the mumps virus. Fujii N; Yokosawa N; Ishida S; Shirakawa S; Kubota T; Indoh T; Fujinaga K; Yashiki T Microbiol Immunol; 1996; 40(10):777-81. PubMed ID: 8981353 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity. Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395 [TBL] [Abstract][Full Text] [Related]
5. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages. Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851 [TBL] [Abstract][Full Text] [Related]
6. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance]. Komiyama T; Akaike M; Satomura K; Okumura H Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348 [TBL] [Abstract][Full Text] [Related]
7. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821 [TBL] [Abstract][Full Text] [Related]
8. Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants. Mechti N; Affabris E; Romeo G; Lebleu B; Rossi GB J Biol Chem; 1984 Mar; 259(5):3261-5. PubMed ID: 6321503 [TBL] [Abstract][Full Text] [Related]
9. 2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites. Affabris E; Romeo G; Belardelli F; Jemma C; Mechti N; Gresser I; Rossi GB Virology; 1983 Mar; 125(2):508-12. PubMed ID: 6301152 [TBL] [Abstract][Full Text] [Related]
10. Gene dosage and down-regulation of the alpha-interferon receptor. Gerdes AM; Hørder M; Bonnevie-Nielsen V Scand J Clin Lab Invest; 1992 May; 52(3):189-92. PubMed ID: 1384107 [TBL] [Abstract][Full Text] [Related]
12. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity. Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443 [TBL] [Abstract][Full Text] [Related]
13. Decrease of interferon-induced 2',5'-oligoadenylate synthetase activity in cirrhotic rat liver. Miyajima I; Sata M; Uchimura Y; Suzuki H; Tanikawa K Kansenshogaku Zasshi; 1995 Dec; 69(12):1383-8. PubMed ID: 8586891 [TBL] [Abstract][Full Text] [Related]
14. Oligo-2',5'-adenylate synthetase activity in cells persistently infected with human T-lymphotropic virus type I (HTLV-I). Fujii N; Kwon KW; Yashiki T; Kimura K; Isogai E; Isogai H; Sekiguchi S; Oguma K Microbiol Immunol; 1992; 36(4):425-9. PubMed ID: 1406369 [TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis]. Karino Y Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526 [TBL] [Abstract][Full Text] [Related]
16. Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the alpha-/beta-interferon genes. Grandér D; Heyman M; Bröndum-Nielsen K; Liu Y; Lundgren E; Söderhäll S; Einhorn S Blood; 1992 Apr; 79(8):2076-83. PubMed ID: 1562733 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of type I interferon receptor by IFN-gamma. Mizukoshi E; Kaneko S; Yanagi M; Ohno H; Matsushita E; Kobayashi K J Interferon Cytokine Res; 1999 Sep; 19(9):1019-23. PubMed ID: 10505744 [TBL] [Abstract][Full Text] [Related]
18. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Hylton W; Cayley J; Dore C; Denman AM Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470 [TBL] [Abstract][Full Text] [Related]
19. Interferon gamma does not induce antiviral resistance in T lymphocytes. Zucca M; Gribaudo G; Ferrara B; Cavallo G; Landolfo S J Biol Regul Homeost Agents; 1988; 2(1):15-8. PubMed ID: 2845724 [TBL] [Abstract][Full Text] [Related]
20. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels. Ramamurthy V; Fleischmann WR J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]